Related Experiment Video
Updated: Aug 8, 2026
Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
Published on: February 27, 2015
Expression profiling of small cellular samples in cancer: less is more
1Department of Pharmacology, University of Pennsylvania Medical Center, Philadelphia, PA 19104-6058, USA.
Abstract:
Expression profiling of tumours from cancer patients has uncovered several genes that are critically important in the progression of a normal cell to an oncogenic phenotype. Leading the way in these discoveries is the use of microarrays, a technology that is currently in transition from basic science applications to use in the clinic. Microarrays can determine the global gene regulation of an individual cancer, which may be useful in formulating an individualised therapy for the patient. Currently, cells used in breast cancer microarray studies often come from either homogenous cultures or heterogeneous biopsy samples. Both cell sources are at a disadvantage in determining the most accurate gene profile of cancer, which often consists of multiple subspecies of cancerous cells within a background of normal cells. Therefore, acquisition of small, but highly specific biopsies for analysis may be required for an accurate expression analysis of the disease. Amplification methods, such as polymerase chain reaction (PCR) and amplified antisense RNA (aRNA) amplification, have been used to amplify the mRNA signal from very small samples, which can then be used for microarray analysis. In this study, we describe the acquisition, amplification, and analysis of very small samples (<10000 cells) for expression analysis and demonstrate that the ultimate resolution of cancer expression analysis, one cell, is both feasible and practical.
Insights
Researchers developed a method to analyze gene expression in tiny cancer cell samples, even single cells. This technique uses amplification methods for accurate cancer expression analysis, paving the way for personalized cancer therapies.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- Gene expression profiling of tumors reveals critical genes in cancer progression.
- Microarray technology is transitioning from research to clinical applications for personalized cancer therapy.
- Current methods using homogenous cultures or heterogeneous biopsies have limitations in accurately profiling complex cancer cell populations.
Purpose of the Study:
- To develop and validate a method for accurate gene expression analysis from very small cancer cell samples.
- To demonstrate the feasibility of single-cell resolution for cancer expression analysis.
- To improve the accuracy of cancer profiling for potential individualized therapy.
Main Methods:
- Acquisition of very small cancer cell samples (<10,000 cells).
- Application of amplification methods, including polymerase chain reaction (PCR) and amplified antisense RNA (aRNA).
- Microarray analysis of amplified mRNA for gene expression profiling.
Main Results:
- Successful acquisition, amplification, and analysis of gene expression from minimal cell samples.
- Demonstrated feasibility and practicality of achieving single-cell resolution in cancer expression analysis.
- The developed method provides accurate gene profiles from small, specific biopsies.
Conclusions:
- Accurate cancer expression analysis is achievable even with extremely limited cell numbers.
- Single-cell resolution analysis is a feasible and practical approach for understanding cancer heterogeneity.
- This technique holds promise for advancing personalized cancer diagnostics and treatment strategies.
